Vitamin E
- Generic Name
- Vitamin E
- Brand Names
- Mvc-fluoride, Vitafol-one
- Drug Type
- Small Molecule
- Chemical Formula
- C29H50O2
- CAS Number
- 59-02-9
- Unique Ingredient Identifier
- N9PR3490H9
- Background
In 1922, vitamin E was demonstrated to be an essential nutrient. Vitamin E is a term used to describe 8 different fat soluble tocopherols and tocotrienols, alpha-tocopherol being the most biologically active. Vitamin E acts as an antioxidant, protecting cell membranes from oxidative damage. The antioxidant effects are currently being researched for use in th...
- Indication
Vitamin E supplementation is indicated for treatment of vitamin E deficiency which can occur in cystic fibrosis, cholestasis and severe liver disease, abetalipoproteinemia or simply poor diet.
- Associated Conditions
- Vitamin Deficiency
- Associated Therapies
- Long-chain omega-3 fatty acid supplementation, Dietary supplementation
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
- Conditions
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- University Hospital Birmingham
- Target Recruit Count
- 3400
- Registration Number
- NCT00553124
- Locations
- 🇬🇧
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom
Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
- Conditions
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- University of Birmingham
- Target Recruit Count
- 515
- Registration Number
- NCT00553345
- Locations
- 🇬🇧
University of Birmingham, Birmingham, England, United Kingdom
Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) Study
- Conditions
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2006-10-06
- Lead Sponsor
- Amsterdam UMC, location VUmc
- Target Recruit Count
- 100
- Registration Number
- NCT00384618
- Locations
- 🇳🇱
VU University Medical Center, Amsterdam, North Holland, Netherlands
Vitamin E to Prevent Mucositis in Children With Cancer
- Conditions
- First Posted Date
- 2006-04-05
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- The Hospital for Sick Children
- Target Recruit Count
- 16
- Registration Number
- NCT00311116
- Locations
- 🇨🇦
The Hospital for Sick Children, Toronto, Ontario, Canada
The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2010-08-11
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 48
- Registration Number
- NCT00188669
- Locations
- 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
Vitamin E in Aging Persons With Down Syndrome
- Conditions
- Interventions
- First Posted Date
- 2003-03-12
- Last Posted Date
- 2012-05-04
- Lead Sponsor
- New York State Institute for Basic Research
- Target Recruit Count
- 350
- Registration Number
- NCT00056329
- Locations
- 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸George Jervis Clinic, Staten Island, New York, United States
🇺🇸Third Age, Inc., Lexington, Kentucky, United States
Laser and Antioxidant Treatment of Diabetic Macular Edema
- Conditions
- First Posted Date
- 2003-02-17
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 40
- Registration Number
- NCT00055042
- Locations
- 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 35533
- Registration Number
- NCT00006392
- Locations
- 🇺🇸
Bethesda North Hospital, Cincinnati, Ohio, United States
🇺🇸Good Samaritan Hospital Cancer Treatment Center, Cincinnati, Ohio, United States
🇺🇸Tod Children's Hospital, Youngstown, Ohio, United States
A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs
- Conditions
- Locations
- 🇺🇸
Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
🇺🇸Case Western Reserve Univ, Cleveland, Ohio, United States
🇺🇸Univ of Pennsylvania, Philadelphia, Philadelphia, Pennsylvania, United States
Laser and Medical Treatment of Diabetic Macular Edema
- Conditions
- First Posted Date
- 2001-11-30
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 60
- Registration Number
- NCT00027287
- Locations
- 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.